Top Tweets for #ibdtwitter
3/3
Take-home: Day 1 scores are valuable clinical adjuncts for early risk assessment in identifying steroid non-responders early ⏱️.
🔗 https://t.co/v5gXs5Xg05
#IBD #GITwitter #MedTwitter #UlcerativeColitis #ibdtwitter
🚨 Couldn’t be prouder to see our very own Creighton rockstar 🎸🤘 @AlHindawiMD craft together this outstanding piece of work 📝
The GI space is beyond lucky to have you 👏 I know how much effort you put into this
#GITwitter #IBDTwitter #MedTwitter #FutureOfGI
#SundayRead☕️ from #CC360 Editor’s desk
💎Best of #ECCO26 & it’s clinical implications
💉IL23 long-term data
🎭JAKis Comparative efficacy
🧒🏻VDZ in peds
🆕AVB114 (stem cell) in perianal CD
✂️LIRiC 10yr f/up
🔮IBD revention w diet in hi-risk ppl
& more
🔗https://t.co/H3Ej8Tupue
Greenhall et al 🚨 #Upadacitinib in Peds #IBD looks promising
BUT 44% relapsed after stepping down 😬
Good news? 86% regained response with re-escalation 🔄
Dosing strategy may need a rethink 👀
#JAKinhibitors #GITwitter #IBDTwitter #MedTwitter
Read: https://t.co/miG1am5OVM
Evicue is probably the most useful app I’ve downloaded in 2026 (in addition o OpenEvidence) to stay on top of evidence-based GI. Ya’ll should try it 🔥
#GItwitter #IBDtwitter
The effect of dose-intensification after secondary loss of response to ustekinumab in Crohn’s disease: Results of the REScUE study
https://t.co/Aw4pzxRb0l
#IBDtwitter
Congratulations to Dr Subhaharan on the oral presentation at ECCO 2026,Stockholm! He presented our prospective study on Transperineal Ultrasound in identifying steroid non-response in ASUC - the TRANSPIRE study.
@BowelUltrasound
#ECCO2026
#ECCO26
#GItwitter
#IBDtwitter
Don’t miss the IUS research from our IBUS members! Here’s the oral presentation details from tomorrow, Thursday, February 19th, 2026👇🏻
🚨 Hitting up #AIBD2025 this year?
Check out their website for the conference agenda, speakers, venue info, and more 👇🏻
https://t.co/NUzdzViTj0
It’s gonna be a banger 💥
📲 DM me if you’re going! 👀
#GITwitter #IBDTwitter #FutureOfGI
@ACG_EBGI @PennIBDDoc @EdwardLoftus2 @RahulSDalalMD @MLongMD @EdBarnesMD @tinahamd @JosephHabibi_MD @DCharabaty @ShimaghavimiMD @clivejmiranda @AmCollegeGastro @ownyourcrohns @jalpa_devi @ibddocmaria @BettenworthDb @BolandBrigid @DanielButlerMD @dr_fcalderaibd @BenClickMD @IBD_Houston @Bealoquebea @PeyrinBiroulet @RishikaChughMD @UmaMahadevanIBD @ibdgijami @CathyLuMD @Iris_Dotan @PhilFleshnerMD @AimenKhanMD @FarrayeIBD @ibdtweets @DrAnuraagJ @IBDHorizons @IBD_FloMD @ElisaBodenIBDMD @mchiorean4 @BowelUltrasound @iUSCAN @MN_GIMD @drsusankais @JHashashMD @MRegueiroMD @IBDmedicaldoc @malloc_doc @amelia_kellar @DrMikeDolinger @deBruynJennifer @salvasapedraza @RuneWilkens 6/8 Caution ☣️
💎 Sev new adv but rec are conditional based on low-quality evidence
💎Lacking data 📈 on comp positioning of 💊💉 and seq strategies after biologic failure
💎 Evidence on 🥘 therapy remains limited
🥦 Diet alone should ❌ delay treatment
#IBDTwitter #GITwitter
@ACG_EBGI @PennIBDDoc @EdwardLoftus2 @RahulSDalalMD @MLongMD @EdBarnesMD @tinahamd @JosephHabibi_MD @DCharabaty @ShimaghavimiMD @clivejmiranda @AmCollegeGastro @ownyourcrohns @jalpa_devi @ibddocmaria @BettenworthDb @BolandBrigid @DanielButlerMD @dr_fcalderaibd @BenClickMD @IBD_Houston @Bealoquebea @PeyrinBiroulet @RishikaChughMD @UmaMahadevanIBD @ibdgijami @CathyLuMD @Iris_Dotan @PhilFleshnerMD @AimenKhanMD @FarrayeIBD 4/8 Updates in Diagnostics and Mild-Mod CD
💩 Fecal Calp 50-100 cut off to diff 🔥 inflamm vs non-inflamm
📷 IUS formally endorsed to assess 🔥
❌ Mesalamine for CD
❌ Budesonide for maintenance
🥘 Diet is reasonable in select pts with mild CD
#GITwitter #IBDtwitter
Not sure how everyone feels about it 🤔
In my opinion, this again emphasizes that EARLY aggressive treatment of CD carries a significantly higher chance of response to any agent, rather than VDZ-specific finding
Similar take away from the PROFILE trial
#GITwitter #IBDtwitter
New research - Vedolizumab in early and late Crohn's disease (LOVE-CD): a phase 4 open-label cohort study
https://t.co/0bti9TqUag
#GITwitter #MedTwitter
8/🧵
In summary, the efficacy of obefazimod (especially the 50mg dose) is consistent and robust across patients with prior inadequate response to ATs, including JAK inhibitors.
Awaiting week 52 maintenance data
#IBD #UC #IBDTwitter #MedTwitter
Our new publication in @FrontGastro_BMJ
Predictors of response to Medical rescue therapy in ASUC: RESCUE-ASC STUDY
- UCEIS < 6
- CRP on day 3 Post rescue <22mg/L
Identifies patients who avoid colectomy
doi: 10.1136/flgastro-2025-103253
#GITwitter
#IBDTwitter
#MedTwitter
🍁Kicking off the fall w 🎥 series focused on #IBD trials
🎯How to incorporate trials in your practice @JHashashMD 8/25
🎯New drugs & RCTs creating a buzz in the IBD @bruce_sands1 9/8 & 9/15
Support by edu grants @abbvie @JNJInnovMed @TakedaPharma
📌Where are you in your🩺
✨ Happiness in Medicine ✨
Nothing compares to the joy of seeing a patient’s healing journey unfold.
From severe inflammation in 2022 ➡️ to healthy mucosa in 2024 — this is what effective and timely therapy can do. 💙
Every ulcer healed, every symptom eased, and every moment of regained quality of life is a victory worth celebrating.
#ibdlibrary #mucosalhealinginibd
The risk of VTE in hospitalized IBD patients extends up to 30 days after discharge.
Our latest publication in @FrontGastro_BMJ
Should we consider extended thromboprophylaxis in all hospitalized IBD patients?
👉 https://t.co/9B6CEIMi88
#IBD #GItwitter #IBDtwitter
Fellows invited too 💁🏻♀️
This fellow 🙋🏻♀️ will be there! Join me!
#IBDTwitter #GITwitter
@UMichGIHep @HFHGastroFellow @hurongastro
@MIGISociety it putting on its first #IBD Regional
https://t.co/TvithFYsvB
@UMichGIHep @HFHGastroFellow @hurongastro @CorewellHealth faculty
Registration: FREE.
What? Free you say? Thats right. FREE.
Why? We want give #IBD providers in Michigan the tools to succeed!
We made an IBD Reel! @virtuahealth #IBD #CD #UC #Crohns #UlcerativeColitis #GutHealth #MedTwitter #GITwitter #IBDTwitter #Gastroenterology #AutoimmuneDisease #ChronicDisease #HealthEquity #IBDAwareness
@CrohnsColitisFn @saia_ibd @AmerGastroAssn @ACG_Gastro
Our very own @DrSanket_Patel , board-certified gastroenterologist, is here to provide a crash course in IBD-aka Crohn’s disease and ulcerative colitis. Because the truth is, IBD is so much more than that bad burrito, and we are here to help!
Honored to join the @AGA_Gastro community as an editorial fellow for Gastroenterology. Excited to learn, contribute, and work alongside an amazing team. Looking forward to a great year ahead! @AmerGastroAssn @SamnaniSunil #GITwitter #AGAFellow #IBDTwitter
📣 Introducing Gastroenterology's new editorial fellows @LashaMD_IBD and @SamnaniSunil. Please join us in welcoming them! Follow this link to view the fellows selected across the entire AGA portfolio:
🔗 https://t.co/0SYCj7XqfP
@PaulMoayyedi
Last Seen Hashtags on Sotwe
pijatsolo
Seen from Indonesia
恶堕
Seen from France
russian girl video
Seen from Pakistan
femboy #bbcdildo
Seen from Mexico
momsonincsest
Seen from Vietnam
女同性恋
Seen from Vietnam
boypussy
Seen from United States
anxiouspanda()**************************************************************************************************************************** filter:native_video()
Seen from Korea
sis
Seen from Sweden
minichat(((())))******filter:videos
Seen from United States
Trends for you
Most Popular Users
Elon Musk 
@elonmusk
241.5M followers
Barack Obama
@barackobama
118.9M followers
Cristiano Ronaldo
@cristiano
114.6M followers
Donald J. Trump
@realdonaldtrump
111.8M followers
Narendra Modi
@narendramodi
107.1M followers
Rihanna
@rihanna
98.7M followers
NASA
@nasa
92.3M followers
Justin Bieber
@justinbieber
91.8M followers
KATY PERRY
@katyperry
90.1M followers
Taylor Swift
@taylorswift13
84M followers
Lady Gaga
@ladygaga
75.5M followers
Virat Kohli
@imvkohli
73.5M followers
Kim Kardashian
@kimkardashian
70.9M followers
YouTube
@youtube
68.8M followers
Neymar Jr
@neymarjr
66.5M followers
Bill Gates
@billgates
65.3M followers
Selena Gomez
@selenagomez
63.1M followers
The Ellen Show
@theellenshow
62.2M followers
CNN
@cnn
61.8M followers
X
@x
60.7M followers